National registry tracks pregnancy risks of transplant drugs
NCT ID NCT01733082
Summary
This study is collecting information about what happens when pregnant women take mycophenolate medications, which are used for organ transplants and autoimmune diseases. Researchers will follow 500 pregnant women in the U.S. who are exposed to these drugs to track pregnancy complications and birth defects in their babies up to one year old. The goal is to better understand the safety risks so doctors and patients can make more informed decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART TRANSPLANTATION, KIDNEY TRANSPLANTATION, LIVER TRANSPLANTATION, AUTOIMMUNE DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Quintiles Outcome
RECRUITINGCambridge, Massachusetts, 02139, United States
Conditions
Explore the condition pages connected to this study.